Bicara Therapeutics Inc. (BCAX) Live Share Price, Invest From India

Bicara Therapeutics Inc. Stock Performance

as on October 24, 2026 at 2:16 pm IST

Day's Low
Day's High
$16.98
Day's Price Range
$17.85
$17.07
0.53%
Downside
4.57%
Upside
52 Week's Low
52 Week's High
$13.70
52-Week Price Range
$30.99
$17.07
19.74%
Downside
81.55%
Upside

Bicara Therapeutics Inc. share price movements today

Previous Close: $17.61
Open: $17.85
Volume: 747.2K
Market Cap: $1.2B
Day's Low - High: $16.98 - $17.85
52 Week Low - High: $13.70 - $30.99

Bicara Therapeutics Inc. Historical Returns

1 Month Return: -13.7 %
3 Month Return: -36.82 %
1 Year Return: -0.41 %
3 Year Return: 0 %
5 Year Return: 0 %

Bicara Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Bicara Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

-3.1

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.68

Industry PE ratio

-7.83

PEG Ratio

0.13

EBITDA

-185.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-41.49%

Bicara Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bicara Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Bicara Therapeutics Inc.	StrongBuy	$1.2B	NA	-5.68	0.00%	0.00%
Moderna	Neutral	$80.9B	-38.72%	-25.39	-12.57%	0.00%
BeOne Medicines	StrongBuy	$43.5B	NA	26.46	87.82%	0.00%
Vertex Pharmaceuticals	StrongBuy	$135.6B	185.49%	30.90	86.04%	0.00%
Regeneron	Buy	$83.1B	40.65%	19.56	84.86%	0.46%

Stock Returns calculator for Bicara Therapeutics Inc. Stock including INR - Dollar returns

The Bicara Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Bicara Therapeutics Inc. investment value today

Current value as on today

₹1,07,716

Returns

₹7,716

(+7.72%)

Returns from Bicara Therapeutics Inc. Stock

-₹408 (-0.41%)

Dollar Impact

₹8,125 (+8.12%)

Analyst Recommendation on Bicara Therapeutics Inc. Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Bicara Therapeutics Inc.. Average target price of $34.4

Bicara Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Bicara Therapeutics Inc..

Current Price

$17.07

Analyzed by

5 Analysts

High

$45

Low

$23

Bicara Therapeutics Inc. target price $0, a slight upside of 0% compared to current price of $17.07. According to 5 analysts rating.

Indian Investors' Interest in Bicara Therapeutics Inc. Stock

Search interest for Bicara Therapeutics Inc. Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 24, 2026 to October 24, 2026

Change:-38% versus previous 30 day period

Bicara Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-15	-19	-20	-26	-41	-32	-40	-41	-60	-59
EBITDA	-12	-17	-17	-20	-36	-27	-36	-37	-56	-55
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-12	-17	-17	-20	-36	-27	-36	-37	-56	-55
Income Tax Expense	0	-	-	0	0	0	0	0	0	0
Net Income	-12	-17	-17	-20	-36	-27	-36	-37	-56	-55
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Bicara Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Income	-37	-39	-82	-155
EBITDA	-37	-51	-67	-137
Interest Expense	0	-	-	-
Depreciation	0	0	0	0
Income Before Tax	-37	-51	-67	-137
Income Tax Expense	0	0	0	0
Net Income	-37	-51	-67	-137
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Bicara Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-12	-17	-17	-20	-36	-27	-36	-37	-56	-55
Operating Cash Flow	-14	-12	-17	-30	-28	-25	-29	-23	-37	-44
Investing Cash Flow	0	0	0	0	-	-	-236	-82	100	-184
Financing Cash Flow	0	0	334	0	0	0	0	31	163	2
Change in Cash	-14	-12	316	-31	-27	-25	-264	-74	226	-226

Bicara Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-37	-51	-67	-137
Operating Cash Flow	-32	-45	-74	-106
Investing Cash Flow	0	0	0	-318
Financing Cash Flow	31	272	334	32
Change in Cash	0	226	259	-393

Global Institutional Holdings in Bicara Therapeutics Inc.

Check out the Institutions with significant holdings in Bicara Therapeutics Inc..

Funds	Holdings
Peter Kolchinsky	10.97%
Vanguard	3.96%
T. ROWE PRICE SMALL-CAP STOCK FUND, INC.	3.30%
iShares	3.16%
Otello Stampacchia	2.75%

See all

Insights on Bicara Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 648.3% return, outperforming this stock by 648.7%
NEGATIVE IMPACT
Price Dip
In the last 3 months, BCAX stock has moved down by -36.8%

About Bicara Therapeutics Inc.

Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, dual-action treatments specifically for solid tumors. At the forefront of their pipeline is ficerafusp alfa, a unique antibody designed to tackle solid cancers. This bifunctional therapeutic agent works by simultaneously engaging the epidermal growth factor receptor (EGFR) and binding to human transforming growth factor beta (TGF-b). Bicara Therapeutics operates as a subsidiary of Biocon Limited.

Organisation	Bicara Therapeutics Inc.
Headquarters	116 Huntington Avenue, Boston, MA, 02116, US
Industry	Biotechnology
CEO	Claire Mazumdar Clemon

Key Management of Bicara Therapeutics Inc.

Name	Title
Mr. Ryan Cohlhepp Pharm.D.	President, COO & Director
Ms. Jennifer Larson	CFO, Treasurer & Principal Accounting Officer
Ms. Sathish Hasige Ph.D.	Senior VP and Head of Technical Operations & Supply Chain
Ms. Angela Windt	VP & Head of Regulatory Affairs
Dr. Claire Mazumdar Clemon M.B.A., Ph.D.	CEO & Director
Ms. Rachel Frank	Vice President of Investor Relations and Corporate Communications
Ms. Lara S. Meisner J.D.	Chief Legal Officer, Compliance Officer & Corporate Secretary
Ms. Pauline Dufresne	Chief People Officer
Ms. Rachel Salazar	SVP of R&D Strategy and Operations
Dr. Jeltje Schulten M.B.A., M.D.	Senior Vice President of Clinical & Medical Affairs

FAQs

What is Bicara Therapeutics Inc. share price today?

Bicara Therapeutics Inc. share price today is $17.07 as on October 24, 2026 at 8:46 am IST at the close of the market. Bicara Therapeutics Inc. share today touched a day high of $17.85 and a low of $16.98.

What is the 52 week high and 52 week low for Bicara Therapeutics Inc. share?

Bicara Therapeutics Inc. share touched a 52 week high of $30.99 on July 7, 2026 and a 52 week low of $13.70 on November 11, 2025. Bicara Therapeutics Inc. stock price today i.e. October 24, 2026 at 8:46 am IST is closed at $17.07,which is 44.92% down from its 52 week high and 24.60% up from its 52 week low.

What is Bicara Therapeutics Inc.'s market capitalisation today?

Bicara Therapeutics Inc. market capitalisation is $0.00T as on October 24, 2026 at 8:46 am IST.

How to invest in Bicara Therapeutics Inc. Stock (BCAX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Bicara Therapeutics Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Bicara Therapeutics Inc. Stock (BCAX) from India?

Indian investors can start investing in Bicara Therapeutics Inc. (BCAX) shares with as little as ₹94.94000244140625 or $1 (as of October 24, 2026 at 9:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Bicara Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on October 24, 2026 at 9:43 am IST). Based on Bicara Therapeutics Inc. share’s latest price of $17.07 as on October 24, 2026 at 8:46 am IST, you will get 0.5858 shares of Bicara Therapeutics Inc.. Learn more about fractional shares .